المؤلفون: Gremese, Elisa, Carletto, Antonio, Padovan, Melissa, Atzeni, Fabiola, Raffeiner, Bernd, Giardina, Anna Rita, Favalli, Ennio Giulio, Erre, Gian Luca, Gorla, Roberto, Galeazzi, Mauro, Foti, Rosario, Cantini, Fabrizio, Salvarani, Carlo, Olivieri, Ignazio, Lapadula, Giovanni, Ferraccioli, Gianfranco

المساهمون: Gremese, Elisa, Carletto, Antonio, Padovan, Melissa, Atzeni, Fabiola, Raffeiner, Bernd, Giardina, Anna Rita, Favalli, Ennio Giulio, Erre, Gian Luca, Gorla, Roberto, Galeazzi, Mauro, Foti, Rosario, Cantini, Fabrizio, Salvarani, Carlo, Olivieri, Ignazio, Lapadula, Giovanni, Ferraccioli, Gianfranco

مصطلحات موضوعية: Adalimumab, Aged, Antibodies, Monoclonal, Humanized, Antirheumatic Agent, Arthritis, Rheumatoid, Dose-Response Relationship, Drug, Etanercept, Female, Human, Immunoglobulin G, Infliximab, Longitudinal Studie, Male, Middle Aged, Obesity, Precision Medicine, Receptors, Tumor Necrosis Factor, Registrie, Remission Induction, Treatment Outcome, Tumor Necrosis Factor-alpha

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/22730143; info:eu-repo/semantics/altIdentifier/wos/WOS:000312939700013; volume:65; issue:1; firstpage:94-100; lastpage:100; journal:ARTHRITIS CARE & RESEARCH; http://hdl.handle.net/11570/3125384Test

الإتاحة: https://doi.org/10.1002/acr.21768Test
http://hdl.handle.net/11570/3125384Test

المؤلفون: Gremese, Elisa, Carletto, Antonio, Padovan, Melissa, Atzeni, Fabiola, Raffeiner, Bernd, Giardina, Anna Rita, Favalli, Ennio Giulio, Erre, Gian Luca, Gorla, Roberto, Galeazzi, Mauro, Foti, Rosario, Cantini, Fabrizio, Salvarani, Carlo, Olivieri, Ignazio, LAPADULA, Giovanni, Ferraccioli, Gianfranco

المساهمون: Gremese, Elisa, Carletto, Antonio, Padovan, Melissa, Atzeni, Fabiola, Raffeiner, Bernd, Giardina, Anna Rita, Favalli, Ennio Giulio, Erre, Gian Luca, Gorla, Roberto, Galeazzi, Mauro, Foti, Rosario, Cantini, Fabrizio, Salvarani, Carlo, Olivieri, Ignazio, Lapadula, Giovanni, Ferraccioli, Gianfranco

مصطلحات موضوعية: Adalimumab, Aged, Antibodies, Monoclonal, Humanized, Antirheumatic Agent, Arthritis, Rheumatoid, Dose-Response Relationship, Drug, Etanercept, Female, Human, Immunoglobulin G, Infliximab, Longitudinal Studie, Male, Middle Aged, Obesity, Precision Medicine, Receptors, Tumor Necrosis Factor, Registrie, Remission Induction, Treatment Outcome, Tumor Necrosis Factor-alpha, Rheumatology

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000312939700013; volume:65; issue:1; firstpage:94; lastpage:100; numberofpages:7; journal:ARTHRITIS CARE & RESEARCH; http://hdl.handle.net/11586/150739Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84871821443

الإتاحة: https://doi.org/10.1002/acr.21768Test
http://hdl.handle.net/11586/150739Test